Notably, inhibiting the activity of triglyceride-hydrolyzing enzymes, such as cholesterol esterase and pancreatic lipase, has emerged as a viable strategy for managing hypercholesterolemia and mitigating its associated complications [28]. The gene discussed is CEL; the disease is Hypercholesterolemia.